Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis.
Giancarlo SborgiaAlfredo NiroValentina PastoreRosa Anna FavaleAlessandra SborgiaSamuele GigliolaGianluigi GiulianiMaria Oliva GrassiMarco CoassinFrancesco AielloCristiana IaculliMichele ReibaldiFrancesco BosciaGiovanni AlessioPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
In vitrectomized eyes for endophthalmitis affected by CME unresponsive to medical therapy, DEX-i had an acceptable safety profile and achieved favorable outcomes. The possibility of suppressing mechanisms for infection control should be taken into account, although correct management of endophthalmitis and long time without reactivation before DEX-i reduce the risk.